Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2017 Q2- Text added to 2017 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
New words:
Advisory, antidilutive, Antimicrobial, begun, carcinoma, category, concurrently, consecutive, convenience, copy, core, customer, declaratory, distinct, Fc, foot, forecasting, fusion, gene, judgement, KEYTRUDA, melanoma, model, opening, Opthotech, pembrolizumab, Premise, principle, proportionate, renal, rental, strict, subtenant, TECENTRIQ, tenant, unamortized
Valuein 2017 Q2 filing- Value in 2017 Q3 filing
Original filings
Filing view